cagrilintide news New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk Cagrilintide - Mile High Compounds

Serotonin and Dopamine: In models of insomnia, DSIP administration has been observed to restore depleted levels of serotonin (5-HT) and dopamine, correcting the neurochemical imbalances driven by sleep deprivation

In our sample, baseline serum BDNF levels did not predict major depression and the clinical characteristics of the patients did not predict their BDNF levels

This blend has been utilized in preclinical research investigating cognitive resilience, energy balance, and neural regeneration

(2013) reported that early-phase elevation of serum levels of various growth factors, including HGF, might be associated with the initiation of liver regeneration after hepatectomy in humans

Meanwhile, reduced expression and translocation of the high-volume insulin-sensitive glucose transporter protein GLUT4 has been found in hippocampal neurons of patients with T2DM, leading to reduced neuronal glucose and ultimately cognitive dysfunction (89)